PegBio Co., Ltd. (HKG:2565)
Hong Kong
· Delayed Price · Currency is HKD 64.60
+0.40 (0.62%)
At close: Feb 27, 2026
PegBio Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
58
Market Cap
25.26B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 242.40K | 133.56K | 122.72% |
| Dec 31, 2018 | 108.84K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genscript Biotech | 6.50B |
| InnoCare Pharma | 1.56B |
| Duality Biotherapeutics | 2.38B |
| Shanghai Junshi Biosciences | 2.71B |
| Biocytogen Pharmaceuticals (Beijing) | 1.30B |
| Shanghai Henlius Biotech | 6.35B |
| Ascentage Pharma Group International | 428.02M |
| Zai Lab | 3.58B |